Latest & greatest articles for heart failure

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on heart failure or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on heart failure and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for heart failure

81. “Case management” can prevent people with heart failure being admitted again

“Case management” can prevent people with heart failure being admitted again “Case management” can prevent people with heart failure being admitted again Discover Portal Discover Portal “Case management” can prevent people with heart failure being admitted again Published on 30 August 2016 doi: Case management that is initiated in hospital and led by specialist nurses may reduce unplanned hospital readmissions and length of hospital stay for adults with heart failure. Case management (...) case management is cost effective – particularly in relation to the NHS. A few studies examined case management that was started in the community. The findings are promising and may lead to further studies that confirm these findings in the UK setting. Commissioners would also need to know other things too, such as the components of case management that are most beneficial and the costs. Share your views on the research. Why was this study needed? Heart failure is a condition where the heart

2019 NIHR Dissemination Centre

82. A blood test threshold for diagnosing heart failure in general practice is reviewed

A blood test threshold for diagnosing heart failure in general practice is reviewed A blood test threshold for diagnosing heart failure in general practice is reviewed Discover Portal Discover Portal A blood test threshold for diagnosing heart failure in general practice is reviewed Published on 3 May 2017 doi: The cut-off level for the blood test NTproBNP appears to provide the best balance of detecting true cases while excluding false positives when lowered to 125 pg/ml. The trial supported (...) by the NIHR included a sample of people presenting to their GP with suspected heart failure. It aimed to see which method was best for identifying those who needed referral: the blood test alone; clinical decision rules based on clinical symptoms; or the combination of both. The blood test alone at the 125 pg/ml cut-off correctly identified 94% of people with heart failure but led to 50% of people who did not have heart failure being referred for further investigation. This threshold is lower than

2019 NIHR Dissemination Centre

83. Telemedicine programme can prolong life for heart failure patients

Telemedicine programme can prolong life for heart failure patients Telemedicine programme can prolong life for heart failure patients Discover Portal Discover Portal Telemedicine programme can prolong life for heart failure patients Published on 20 November 2018 doi: A comprehensive programme of daily telemedicine monitoring and 24-hour access to a physician-led hotline can reduce the number of deaths and the time spent in hospital, among patients with heart failure. A year-long study of 1,571 (...) patients who had been admitted to hospital with heart failure within the past 12 months found that those assigned to daily telemonitoring, monthly health education and telephone support from specialist staff, were 30% less likely to die than those assigned to usual care. This was a 3 percentage point reduction from 11% per year in the control group to 8% in the telemedicine group. This group also spent around a third fewer days in hospital. This suggests telemedicine could make a real difference

2019 NIHR Dissemination Centre

84. Home-based cardiac rehabilitation for heart failure has high rates of participation

Home-based cardiac rehabilitation for heart failure has high rates of participation Home-based cardiac rehabilitation for heart failure has high participation Discover Portal Discover Portal Home-based cardiac rehabilitation for heart failure has high rates of participation Published on 8 January 2019 doi: Home-based cardiac rehabilitation for people with heart failure improves quality of life at 12 months compared with usual care. Among those allocated to rehabilitation, 90% remained (...) was this study needed? Heart failure affects around 900,000 people in the UK. Despite the effectiveness of cardiac rehabilitation in reducing re-admission and risk of death from heart disease, and in improving quality of life, availability and attendance in the UK are poor. On average, only 43% of people eligible actually attend, and this varies from 13 to 88% around the country. Efforts to improve access by exploring newer more accessible alternative strategies to hospital-based rehabilitation are required

2019 NIHR Dissemination Centre

85. Cost-Effectiveness of a Home Visit Program for Patients with Heart Failure in Brazil: Evidence from a Randomized Clinical Trial. Full Text available with Trip Pro

Cost-Effectiveness of a Home Visit Program for Patients with Heart Failure in Brazil: Evidence from a Randomized Clinical Trial. Estimate the cost-effectiveness of a nurse-led home visit (HV) intervention as compared with the standard HF management, within a randomized clinical trial in Brazil.Cost-effectiveness study within a randomized trial.To assess the cost-effectiveness of four home visits and four telephone calls by nurses in the management of patients with HF within a randomized

2019 Value in health regional issues Controlled trial quality: uncertain

86. Disease management interventions for heart failure. Full Text available with Trip Pro

Disease management interventions for heart failure. Despite advances in treatment, the increasing and ageing population makes heart failure an important cause of morbidity and death worldwide. It is associated with high healthcare costs, partly driven by frequent hospital readmissions. Disease management interventions may help to manage people with heart failure in a more proactive, preventative way than drug therapy alone. This is the second update of a review published in 2005 and updated (...) in 2012.To compare the effects of different disease management interventions for heart failure (which are not purely educational in focus), with usual care, in terms of death, hospital readmissions, quality of life and cost-related outcomes.We searched CENTRAL, MEDLINE, Embase and CINAHL for this review update on 9 January 2018 and two clinical trials registries on 4 July 2018. We applied no language restrictions.We included randomised controlled trials (RCTs) with at least six months' follow-up

2019 Cochrane

87. Chronic congestive heart failure

Chronic congestive heart failure Chronic congestive heart failure - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Chronic congestive heart failure Last reviewed: February 2019 Last updated: January 2019 Summary A complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood. It is a major and growing public health (...) problem. It is the only cardiovascular disease that is increasing in incidence and prevalence, partly because the population is ageing, but also because of improved cardiovascular interventions for disease processes that reduce early mortality but may result in cardiac changes that lead to heart failure. The key manifestations are dyspnoea and fatigue, which may limit exercise tolerance, and fluid retention, which may lead to pulmonary congestion and peripheral oedema. Diagnosis is largely clinical

2019 BMJ Best Practice

88. Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial. Full Text available with Trip Pro

Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial. Morphine is shown to relieve chronic breathlessness in chronic obstructive pulmonary disease. There are no definitive data in people with heart failure. We aimed to determine the effectiveness and cost-effectiveness of 12 weeks morphine therapy for the relief of chronic breathlessness in people with chronic heart failure compared with placebo.Parallel group, double-blind (...) .We could not answer our primary objectives due to inadequate power. However, we provide novel placebo-controlled medium-term benefit and safety data useful for clinical practice and future trial design. Morphine should only be prescribed in this population when other measures are unhelpful and with early management of side effects.© 2019 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

2019 ESC heart failure Controlled trial quality: predicted high

89. Which tools are available to help healthcare professionals to recognize palliative care needs in patients with chronic heart failure: a systematic review.

Which tools are available to help healthcare professionals to recognize palliative care needs in patients with chronic heart failure: a systematic review. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

90. Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs): systematic review and meta-analysis of observational cohort studies conducted in large healthcare database

Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs): systematic review and meta-analysis of observational cohort studies conducted in large healthcare database Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2019 PROSPERO

91. The efficacy of psychological interventions on health-related quality of life for heart failure patients with depression: a systematic review

The efficacy of psychological interventions on health-related quality of life for heart failure patients with depression: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

92. The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure - a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure - a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate

2019 PROSPERO

93. Efficacy and safety of 4 personal Chinese patent medicines in the treatment of chronic heart failure: a network meta-analysis

Efficacy and safety of 4 personal Chinese patent medicines in the treatment of chronic heart failure: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

94. Uric acid and risk of heart failure mortality: a dose-response meta-analysis of prospective cohort studies

Uric acid and risk of heart failure mortality: a dose-response meta-analysis of prospective cohort studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

95. Health literacy and outcomes among patients with heart failure: a systematic review and meta-analysis protocol

Health literacy and outcomes among patients with heart failure: a systematic review and meta-analysis protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

96. Relationship between serum chloride concentration and mortality risk in patients with heart failure: a meta-analysis

Relationship between serum chloride concentration and mortality risk in patients with heart failure: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

97. Clinical efficacy and safety of shenqi fuzheng injection for the treatment of chronic heart failure: a meta-analysis and systematic review

Clinical efficacy and safety of shenqi fuzheng injection for the treatment of chronic heart failure: a meta-analysis and systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

98. Clinical efficacy and safety of danhong injection for the treatment of chronic heart failure: a meta-analysis and systematic review

Clinical efficacy and safety of danhong injection for the treatment of chronic heart failure: a meta-analysis and systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

99. Chinese herbal preparations for chronic heart failure: a protocol for umbrella systematic review

Chinese herbal preparations for chronic heart failure: a protocol for umbrella systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

100. The diagnostic thresholds of N-terminal pro-B-type natriuretic peptide (NTproBNP) in acute heart failure: a systematic review and collaborative individual patient data meta-analysis

The diagnostic thresholds of N-terminal pro-B-type natriuretic peptide (NTproBNP) in acute heart failure: a systematic review and collaborative individual patient data meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO